Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Curr Opin Rheumatol. 2011 Jan;23(1):43–49. doi: 10.1097/BOR.0b013e32833ee946

Table 1.

Potential impact of understanding functional T cell lineages in GCA

A. Diagnostics
Determine T cell frequencies in diagnostic work-up
Monitor T cell frequencies as a marker of disease activity
Evaluate type and frequency of tissue-infiltrating T cells
Example: IL-17-producing patients with MS are non-responders to IFN-β Tx
B. Therapeutics
Block T cell cytokine to disrupt inflammatory end pathway
Target antigen-presenting cells to inhibit T cell differentiation
Interrupt T cell recruitment to vessel wall or in situ activation
Example: Therapeutic anti-IL-17 antibodies in Rheumatoid Arthritis
C. Pathogenic concepts
Use disease-relevant T cells as a tool to identify the disease instigator(s)
Separate GCA from other disease processes
Example: Chromogranin-specific T cells cause islet cell destruction and diabetes
HHS Vulnerability Disclosure